Andy Coravos (@andreacoravos) is the CEO/co-founder of Elektra Labs, building a digital medicine platform focusing on digital biomarkers for decentralized clinical trials. She serves as a research collaborator at the Harvard-MIT Center for Regulatory Sciences. Formerly, she served as an Entrepreneur in Residence at the FDA working in the Digital Health Unit (DHU), focusing on the Pre-Cert program and policies around software-as-a-medical-device and AI/ML. Previously, Andy worked as a software engineer at Akili Interactive Labs, a leading digital therapeutic company. Before grad school, Andy worked at KKR, a private equity firm, and at McKinsey & Company, a management consulting firm, where she focused on the healthcare industry. She serves on the Board of the Digital Medicine Society (DiMe), and she’s an advisor to the Biohacking Village at DEF CON.